Clinical Trial Update: Pilot Study on BP1.4979 Effect on Binge Eating Disorders [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating BP1.4979 for binge-eating disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• BP1.4979

Snippet

Sponsor: Bioprojet | Conditions: Binge-Eating Disorder | Phase 2 | Status: COMPLETED